Hibrow Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HIBROW HLTHCARE, and what generic and branded alternatives to HIBROW HLTHCARE drugs are available?
HIBROW HLTHCARE has eleven approved drugs.
Drugs and US Patents for Hibrow Hlthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hibrow Hlthcare | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 211621-002 | Sep 16, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Hibrow Hlthcare | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 211621-001 | Sep 16, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Hibrow Hlthcare | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 213090-001 | Aug 25, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.